Over the past eight years, Skild has powered the Community College Innovation Challenge (CCIC), a vital program led by the American Association of Community Colleges (AACC). We’re thrilled to announce that the 2022 challenge is now open for submissions!
Designed to boost interest and proficiency in Science, Technology, Engineering and Math (STEM), Samsung Solve for Tomorrow is a nationwide contest that challenges public school teachers and students in grades 6-12 to show how STEM can be applied to help improve their local community.
The NSF 2026 Idea Machine is a competition to help set the U.S. agenda for fundamental research in science and engineering. Participants can earn prizes and receive public recognition by suggesting the pressing research questions that need to be answered in the coming decade, the next set of “Big Ideas” for future investment by the National Science Foundation (NSF). It's an opportunity for...
The Community College Innovation Challenge (CCIC) is a prestigious, two-stage competition where community college teams use science, technology, engineering and mathematics (STEM) to innovate solutions to real-world problems, compete for cash awards, and earn full travel support (students and faculty) to attend an Innovation Boot Camp in Washington, D.C.
For the second year, the National Science Foundation and the American Association of Community Colleges have challenged students enrolled in community colleges to propose innovative science, technology, engineering and mathematics (STEM)-based solutions to perplexing, real-world problems. An incentive: Teams submitting top ideas receive professional coaching and cash prizes.
Join the nation’s foremost competition encouraging innovation, entrepreneurship, and creativity in students who are working on cutting-edge inventions at their colleges and universities nationwide. Outstanding inventions in STEM and other creative fields are judged by a panel of National Inventors Hall of Fame Inductees, United States Patent and Trademark Office officials, and top AbbVie...
